New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 9, 2012
20:50 EDTMNOVMedicNova receives notice of patent allowance for asthma treatment
MediciNova announced that it has been granted a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application, which covers the use of MN-221 for the treatment of acute exacerbations of asthma.
News For MNOV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 23, 2014
19:02 EDTMNOVMedicNova has enrolled 150 of the 250 patients for phase 2b trial of MN-166
MediciNova announced that, as of September 15, the ongoing phase 2b trial of MN-166 in progressive multiple sclerosis had enrolled 150 of the 250 subjects planned to be enrolled. Enrollment is expected to be completed during 1Q15.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use